Global Infertility Treatment Market is projected to reach USD 3.5 Billion by 2032 at a robust CAGR of 8%

Posted on 2024-07-01 by Future Market Insights in Healthcare // 0 Comments

The global infertility treatment market has reached a monumental milestone, exceeding a value of over USD 1.5 billion in 2021, marking a significant achievement for the industry. This remarkable growth underscores the industry’s resilience and promising outlook for the future. Experts in the field project a continued upward trajectory, with a robust Compound Annual Growth Rate (CAGR) of 8% anticipated from 2022 to 2032. By the end of this period, the market is forecasted to soar past a remarkable USD 3.5 billion valuation, demonstrating sustained growth and demand.

The surge in demand for advanced infertility treatments has been a driving force behind this substantial market expansion, attributed to a global rise in infertility rates. Responding adeptly to this challenge, the industry has witnessed widespread adoption of innovative solutions like Assisted Reproductive Technology (ART), showcasing a commitment to addressing the evolving needs of patients worldwide.

Request a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14317

Several factors contribute to this market growth:

Rising Global Infertility Rates: A significant increase in infertility rates worldwide is prompting individuals and couples to seek advanced and effective treatment options. These escalating figures highlight the crucial need for accessible and innovative solutions, driving industry investment in research and development.
Demand for Advanced Treatments: The growing demand for advanced infertility treatments reflects a desire for higher success rates and improved outcomes. This trend positions the market for continued expansion as new technologies and procedures emerge.
Focus on Innovation: The industry’s commitment to innovation is a key growth factor. Advancements in Assisted Reproductive Technologies (ART) and other treatment options empower healthcare providers to deliver exceptional patient care.

This is intended to raise awareness about the expanding global infertility treatment market and the factors driving its growth.

Key Takeaways: Infertility Treatment Market

The global infertility treatment market is booming, expected to reach USD 3.5 billion by 2032, growing at a healthy 8% annually.
The UK leads the market due to declining fertility rates, numerous clinics, and popularity of assisted reproductive technologies (ART) like IVF.
The US market is also strong with rising infertility (e.g., PCOS), a rapidly evolving healthcare system, and wider adoption of advanced fertility treatments.
Increasing PCOS cases in the US are a key driver, affecting 6-12% of reproductive-aged women.
Advanced options like donor egg IVF and ART procedures like IVF and GIFT are gaining traction due to their higher success rates.

Competitive Landscape:

Leading infertility treatment providers are continually expanding their product offerings and services to attract more customers. They have adopted various strategies to gain a competitive edge in the global infertility treatment market, such as partnerships, acquisitions, mergers, collaborations, awareness campaigns, advertisements, and establishing new treatment centers and clinics. For instance:

In August 2021, Merck Specialties Pvt Ltd launched the Pergoveris Pen for advanced infertility treatment in India.
In 2022, Vios Fertility Institute, in partnership with TMRW Life Sciences, introduced state-of-the-art cryo management solutions for fertility specimens.

Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14317

Key Companies Covered:

Thermo Fisher Scientific (USA)
Cook Group (USA)
Vitrolife (Sweden)
IVFtech APS (Denmark)
Hamilton Thorne Ltd. (USA)
Esco Micro Pte Ltd. (Singapore)
Genea Biomedx Ltd. (Australia)
FUJIFILM Irvine Scientific (USA)
Baker Company INC. (USA)

Key Segments:

By Product:

Equipment
- Microscopes
- Imaging Systems
- Sperm Analyser Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
Media & Consumables
Accessories

By Procedure:

Assisted Reproductive Technology
- In Vitro Fertilization
  - Intracytoplasmic Morphologically Selected Sperm Injection
  - Gamete Donation
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteriscopy
- Varicocelectomy
- Laparotomy
- Tubal Ligation Reversal
- Microsurgical Reconstruction
  - Vasovasostomy
  - Vasoepididymostomy
Other Infertility Treatment Procedures

By Patient Type:

Female Infertility Treatment
Male Infertility Treatment

By End User:

Fertility Centres
Hospitals & Surgical Clinics
Cryobanks
Research Institutes

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

A Detailed Full Report: https://www.futuremarketinsights.com/checkout/14317

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick